CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mallinckrodt IP v. InnoPharma Licensing LLC

1:16-cv-01116

Overview

Case Number 1:16-cv-01116
Filing Date 2016-12-01
Status Terminated
Termination Date 2017-05-09
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

InnoPharma, Inc. Operating Company

Represented By

5 Attorneys Listed

Robert J. Scheffel

UNDELIVERABLE EMAIL 8/28/2018

Mark A. Pacella

Email: mpacella@kviplaw.com

Karin A. Hessler

UNDELIVERABLE EMAIL 8/19/2019

Alexander B. Owczarczak

Email: aowczarczak@wiley.law

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

InnoPharma Licensing LLC NPE (Patent Assertion Entity)

Represented By

5 Attorneys Listed

Robert J. Scheffel

UNDELIVERABLE EMAIL 8/28/2018

Mark A. Pacella

Email: mpacella@kviplaw.com

Karin A. Hessler

UNDELIVERABLE EMAIL 8/19/2019

Alexander B. Owczarczak

Email: aowczarczak@wiley.law

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Plaintiff

Mallinckrodt IP NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Thomas C. Grimm

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2018-07-24
1:18-cv-01090

Mallinckrodt Hospital Products IP Ltd. v. B. Braun Medical Inc.

U.S. Family Sibling (["US9987238"])
Status: DED
U.S. District Court 2017-05-31
1:17-cv-00660

Mallinckrodt IP v. B. Braun Medical Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9399012
Reduced dose intravenous acetaminophen
Filed: 2008-11-13
Issued: 2016-07-26
Active (4.8 yrs remaining) +1032d PTA
Expires: 2031-09-11

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1032 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Respond to Defendants' Counterclaims to March 10, 2017 - filed by Mallinckrodt IP. (Tigan, Jeremy) (Entered: 02/23/2017)
Entry #13 • 2017-02-23 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer Complaint to February 3, 2017 - filed by InnoPharma Licensing LLC, InnoPharma, Inc.. (Gattuso, Dominick) (Entered: 12/22/20...
Entry #8 • 2016-12-22 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT for Patent Infringement filed against InnoPharma Licensing LLC, InnoPharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2038765.) - filed by Mallinckrodt IP. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(sar) (Entered: 12/01/2016)

Entry #1 • 2016-12-01
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 12/01/2016)

Entry #2 • 2016-12-01
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Plaintiff did not receive Notice with respect to U.S. Patent No. 9,399,012. Date of Expiration of Patent: September 11, 2031 with an extensionfor pediatric exclusivity until: March 11, 2032. Thirty Month Stay Deadline: N/A (sar) (Entered: 12/01/2016)

Entry #3 • 2016-12-01
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,399,012 B2;. (sar) (Entered: 12/01/2016)

Entry #4 • 2016-12-01
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc for Mallinckrodt IP filed by Mallinckrodt IP. (sar) (Entered: 12/01/2016)

Entry #5 • 2016-12-01
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc